JODIE COLMAN: Open Payments
NPI 1366815557 · WESTLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 83 payments from 21 companies in 2025. Trend: 2023 $1,589 · 2024 $1,655 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $297 |
| GlaxoSmithKline, LLC. | 17 | $190 |
| ABBVIE INC. | 10 | $178 |
| Novo Nordisk Inc | 10 | $168 |
| Vanda Pharmaceuticals Inc. | 6 | $144 |
| PFIZER INC. | 4 | $76 |
| Medtronic, Inc. | 2 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Neurelis, Inc. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, HETLIOZ, QULIPTA, FARXIGA, BREZTRI, Rybelsus, INCEPTIV.
Industry payments across MI — which companies pay providers there.
